Researchers at Rockefeller University focused on the NOVA1 gene. This gene is crucial for brain development and is found in many animals. But the human version of NOVA1 contains a special difference in its sequence.
Biocon has inked a pact with California-based Quark Pharma to co-develop medicines based on the emerging siRNA technology.